Please provide your email address to receive an email when new articles are posted on . The IC-OS definition of immune checkpoint inhibitor-associated myocarditis demonstrated good diagnostic ...

Mounting data on mRNA vaccination against COVID-19 continued to suggest a small excess risk of myocarditis, especially in young men and adolescent boys. Based on voluntary reports to the passive ...

The estimated incidence of myocarditis among patients that have received at least one dose of the Pfizer-BioNTech (BNT162b2) mRNA vaccine against coronavirus disease 2019 (COVID-19) was 2.13 cases per ...

In a recent study posted to the medRxiv* preprint server, a team of researchers from the United States (US) performed a time case surveillance of myopericarditis following coronavirus disease 2019 ...

AMSTERDAM -- Anti-inflammatory immunosuppressant anakinra (Kineret) held no survival benefit for acute myocarditis, the randomized phase IIb ARAMIS trial showed. The interleukin-1 receptor antagonist ...

Acute myocarditis is an inflammatory condition of the heart muscle that is most commonly caused by viral infection. Bacterial myocarditis, particularly that caused by nontyphoidal Salmonella (NTS), is ...

Despite being younger and having fewer comorbidities, patients with acute myocarditis (AM) had a significantly higher risk for 30-day and long-term mortality than those with unexplained chest pain.

Reports of myocarditis developing after receipt of one of the mRNA-based COVID-19 vaccines from Pfizer/BioNTech and Moderna are understandably concerning, though the complication appears rare and has ...

Rates of myocarditis remain low following administration of a third dose of the COVID-19 vaccine from Pfizer/BioNTech, with the possibility of even lower rates than were seen after the initial ...

Now that the Pfizer-BioNTech COVID-19 vaccine has been approved for use in children ages 5 through 11, there's concern that some will develop myocarditis, a swelling of the heart muscle. But it's not ...